🌿 Environment 4d ago · Jonathan Gardner

View Channel →

0 0 Save Read Full Article Source ↗ 👁 1 💬 0

Eli Lilly impressed with its amylin-Zepbound combination data. Elsewhere, Novo demonstrated continued weight loss following a switch to oral and AbbVie and Boehringer gave glimpses into their contenders.

Sign in to join the discussion

A climate threat may lurk beneath Antarctica's last great unknown

Earth News - Earth Science News, Earth Science, Climate Change · 1d ago

Climate leaders push for more solar energy by 2030

EHN · 1d ago

‘Wait for the clock to run out’: Louisiana offshore wind energy leaders look beyond Trump

EHN · 1d ago

Clarence Thomas is in the hot seat for US Supreme Court’s biggest climate case in years

EHN · 1d ago

Sea levels on the West Coast to rise by a foot as Kelvin waves hit

EHN · 1d ago

Heat-trapping gas once frozen in Arctic ground is slowly leaking and warming the planet

Earth News - Earth Science News, Earth Science, Climate Change · 1d ago